Cargando…

A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity

BACKGROUND: The treatment of cocaine toxicity is an important subject for emergency physicians. We investigated the effects of dexmedetomidine, moxonidine and alpha-methyldopa on acute cocaine toxicity in mice. OBJECTIVES: The aim of this study was to evaluate the effects of dexmedetomidine, moxonid...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyit, Murat, Erdur, Bulent, Kortunay, Selim, Yuksel, Aykut, Yilmaz, Atakan, Ozen, Mert, Uyanik, Aykut, Tomruk, Onder, Ergin, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537789/
https://www.ncbi.nlm.nih.gov/pubmed/26290748
http://dx.doi.org/10.5812/ircmj.17(5)2015.18780
_version_ 1782385945405816832
author Seyit, Murat
Erdur, Bulent
Kortunay, Selim
Yuksel, Aykut
Yilmaz, Atakan
Ozen, Mert
Uyanik, Aykut
Tomruk, Onder
Ergin, Ahmet
author_facet Seyit, Murat
Erdur, Bulent
Kortunay, Selim
Yuksel, Aykut
Yilmaz, Atakan
Ozen, Mert
Uyanik, Aykut
Tomruk, Onder
Ergin, Ahmet
author_sort Seyit, Murat
collection PubMed
description BACKGROUND: The treatment of cocaine toxicity is an important subject for emergency physicians. We investigated the effects of dexmedetomidine, moxonidine and alpha-methyldopa on acute cocaine toxicity in mice. OBJECTIVES: The aim of this study was to evaluate the effects of dexmedetomidine, moxonidine and alpha-methyldopa in a mouse model of acute cocaine toxicity. MATERIALS AND METHODS: We performed an experiment consisting of four groups (n = 25 each). The first group received normal saline solution, the second group received 40 µg/kg of dexmedetomidine, the third group received 0.1 mg/kg of moxonidine and the fourth group received 200 mg/kg of alpha-methyldopa, all of which were intraperitoneally administered 10 minutes before cocaine hydrochloride (105 mg/kg). All animals were observed for seizures (popcorn jumping, tonic-clonic activity, or a loss of the righting reflex) and lethality over the 30 minutes following cocaine treatment. RESULTS: The ratio of animals with convulsions was lower in all treated groups when compared to the control (P < 0.001). Furthermore, 68% (n = 17) of animals in the dexmedetomidine group, 84% (n = 21) of the alpha-methyldopa group, 92% (n = 23) of the moxonidine group and 100% (n = 25) of the control group showed evidence of seizure activity (P = 0.009). Cocaine-induced lethality was observed in 12% (n = 3) of the dexmedetomidine group, 48% (n = 12) of the alpha-methyldopa group, 52% (n = 13) of the moxonidine group, and 72% (n = 18) of the control group (P < 0.001). All treatments prolonged the time to seizure, which was longest in the dexmedetomidine group (P > 0.05). In addition, the time to lethality was also longer in the same group (P < 0.001). CONCLUSIONS: The present study provides the first experimental evidence in support of dexmedetomidine treatment for cocaine-induced seizures. Premedication with dexmedetomidine reduces seizure activity in a mouse model of acute cocaine toxicity. In addition, while dexmedetomidine may be effective, moxonidine and alpha-methyldopa did not effectively prevent cocaine-induced lethality.
format Online
Article
Text
id pubmed-4537789
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-45377892015-08-19 A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity Seyit, Murat Erdur, Bulent Kortunay, Selim Yuksel, Aykut Yilmaz, Atakan Ozen, Mert Uyanik, Aykut Tomruk, Onder Ergin, Ahmet Iran Red Crescent Med J Research Article BACKGROUND: The treatment of cocaine toxicity is an important subject for emergency physicians. We investigated the effects of dexmedetomidine, moxonidine and alpha-methyldopa on acute cocaine toxicity in mice. OBJECTIVES: The aim of this study was to evaluate the effects of dexmedetomidine, moxonidine and alpha-methyldopa in a mouse model of acute cocaine toxicity. MATERIALS AND METHODS: We performed an experiment consisting of four groups (n = 25 each). The first group received normal saline solution, the second group received 40 µg/kg of dexmedetomidine, the third group received 0.1 mg/kg of moxonidine and the fourth group received 200 mg/kg of alpha-methyldopa, all of which were intraperitoneally administered 10 minutes before cocaine hydrochloride (105 mg/kg). All animals were observed for seizures (popcorn jumping, tonic-clonic activity, or a loss of the righting reflex) and lethality over the 30 minutes following cocaine treatment. RESULTS: The ratio of animals with convulsions was lower in all treated groups when compared to the control (P < 0.001). Furthermore, 68% (n = 17) of animals in the dexmedetomidine group, 84% (n = 21) of the alpha-methyldopa group, 92% (n = 23) of the moxonidine group and 100% (n = 25) of the control group showed evidence of seizure activity (P = 0.009). Cocaine-induced lethality was observed in 12% (n = 3) of the dexmedetomidine group, 48% (n = 12) of the alpha-methyldopa group, 52% (n = 13) of the moxonidine group, and 72% (n = 18) of the control group (P < 0.001). All treatments prolonged the time to seizure, which was longest in the dexmedetomidine group (P > 0.05). In addition, the time to lethality was also longer in the same group (P < 0.001). CONCLUSIONS: The present study provides the first experimental evidence in support of dexmedetomidine treatment for cocaine-induced seizures. Premedication with dexmedetomidine reduces seizure activity in a mouse model of acute cocaine toxicity. In addition, while dexmedetomidine may be effective, moxonidine and alpha-methyldopa did not effectively prevent cocaine-induced lethality. Kowsar 2015-06-01 /pmc/articles/PMC4537789/ /pubmed/26290748 http://dx.doi.org/10.5812/ircmj.17(5)2015.18780 Text en Copyright © 2015, Iranian Red Crescent Medical Journal. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Seyit, Murat
Erdur, Bulent
Kortunay, Selim
Yuksel, Aykut
Yilmaz, Atakan
Ozen, Mert
Uyanik, Aykut
Tomruk, Onder
Ergin, Ahmet
A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity
title A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity
title_full A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity
title_fullStr A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity
title_full_unstemmed A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity
title_short A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity
title_sort comparison of dexmedetomidine, moxonidine and alpha-methyldopa effects on acute, lethal cocaine toxicity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537789/
https://www.ncbi.nlm.nih.gov/pubmed/26290748
http://dx.doi.org/10.5812/ircmj.17(5)2015.18780
work_keys_str_mv AT seyitmurat acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT erdurbulent acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT kortunayselim acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT yukselaykut acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT yilmazatakan acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT ozenmert acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT uyanikaykut acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT tomrukonder acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT erginahmet acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT seyitmurat comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT erdurbulent comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT kortunayselim comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT yukselaykut comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT yilmazatakan comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT ozenmert comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT uyanikaykut comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT tomrukonder comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity
AT erginahmet comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity